Johnson & Johnson told to pay $8bn to man over unwanted breast growth
US drugs giant Johnson & Johnson (JNJ) has been ordered to pay $8bn (£6.6bn) in damages to man who grew breast tissue after taking a antipsychotic drug as a child.
A Philadelphia jury on Tuesday awarded 26-year-old Nicholas Murray $8bn in damages, on top of $680,000 already awarded in 2015.
The verdict comes after Murray was proscribed antipsychotic drug Risperdal in 2003 as a child. The drug was initially used to treat bipolar disorder and schizophrenia, but was expanded to treat autism. Murray developed breast tissue after taking the drug, which was “humiliating” and “often painful”, his lawyers said.
Murray’s lawyers argued that Johnson & Johnson’s subsidiary Janssen did not make him aware that the drug could lead to the development of female breast tissue. Tuesday’s verdict was the first time a jury ruled on the case.